Axogen (AXGN) Gross Margin (2010 - 2026)
Axogen's quarterly Gross Margin came in at 75.16% in Q1 2026, up 322.0% year-on-year from 17.81% in Q1 2025, and up 1.38% quarter-over-quarter from 74.13% in Q4 2025.
Axogen has reported Gross Margin for 17 years, with the latest figure at 75.16% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 322.0% year-over-year to 75.16%; the trailing twelve-month figure through Mar 2026 stood at 75.01% (up 84.0% YoY), and the FY2025 full-year result was 74.31%, down 148.0% from the prior year.
- Gross Margin for Q1 2026 stood at 75.16%, up from 74.13% in the prior quarter.
- The five-year high for Gross Margin was 83.29% in Q3 2022, with the low at 67.46% in Q4 2022.
- Average Gross Margin over 5 years is 76.29%, with a median of 76.06% recorded in 2024.
- Year-over-year, Gross Margin sank 1533 bps in 2022 and jumped 715 bps in 2023.
- Tracing AXGN's Gross Margin over 5 years: stood at 67.46% in 2022, then gained by 11 bps to 74.6% in 2023, then grew by 2 bps to 76.06% in 2024, then fell by 3 bps to 74.13% in 2025, then gained by 1 bps to 75.16% in 2026.
- The last three Gross Margin figures came in at 75.16% (Q1 2026), 74.13% (Q4 2025), and 76.55% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | 75.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.16% |
| Dec 31, 2025 | 74.13% |
| Sep 30, 2025 | 76.55% |
| Jun 30, 2025 | 74.16% |
| Mar 31, 2025 | 71.94% |
| Dec 31, 2024 | 76.06% |
| Sep 30, 2024 | 74.91% |
| Jun 30, 2024 | 73.77% |
| Mar 31, 2024 | 78.83% |
| Dec 31, 2023 | 74.60% |
| Sep 30, 2023 | 76.82% |
| Jun 30, 2023 | 77.71% |
| Mar 31, 2023 | 77.71% |
| Dec 31, 2022 | 67.46% |
| Sep 30, 2022 | 83.29% |
| Jun 30, 2022 | 81.76% |
| Mar 31, 2022 | 82.11% |
| Dec 31, 2021 | 82.79% |
| Sep 30, 2021 | 83.21% |
| Jun 30, 2021 | 78.88% |
| Mar 31, 2021 | 83.34% |
| Dec 31, 2020 | 83.19% |
| Sep 30, 2020 | 82.96% |
| Jun 30, 2020 | 74.66% |
| Mar 31, 2020 | 80.15% |
| Dec 31, 2019 | 82.67% |
| Sep 30, 2019 | 84.21% |
| Jun 30, 2019 | 84.11% |
| Mar 31, 2019 | 84.05% |
| Dec 31, 2018 | 84.47% |
| Sep 30, 2018 | 84.71% |
| Jun 30, 2018 | 84.91% |
| Mar 31, 2018 | 84.28% |
| Dec 31, 2017 | 84.60% |
| Sep 30, 2017 | 84.39% |
| Jun 30, 2017 | 84.99% |
| Mar 31, 2017 | 84.35% |
| Dec 31, 2016 | 83.96% |
| Sep 30, 2016 | 84.85% |
| Jun 30, 2016 | 85.22% |
| Mar 31, 2016 | 82.67% |
| Dec 31, 2015 | 81.88% |
| Sep 30, 2015 | 82.70% |
| Jun 30, 2015 | 83.80% |
| Mar 31, 2015 | 80.15% |
| Dec 31, 2014 | 80.04% |
| Sep 30, 2014 | 80.82% |
| Jun 30, 2014 | 78.93% |
| Mar 31, 2014 | 77.65% |
| Dec 31, 2013 | 80.03% |
| Sep 30, 2013 | 78.01% |
| Jun 30, 2013 | 77.87% |
| Mar 31, 2013 | 73.86% |
| Dec 31, 2012 | 76.60% |
| Sep 30, 2012 | 72.63% |
| Jun 30, 2012 | 75.06% |
| Mar 31, 2012 | 73.44% |
| Dec 31, 2011 | 60.85% |
| Sep 30, 2011 | 0.91% |
| Jun 30, 2011 | 65.38% |
| Mar 31, 2011 | 69.79% |
| Dec 31, 2010 | -4.22% |
| Sep 30, 2010 | 79.92% |